✦ LIBER ✦

Expressive writing in early breast cancer survivors

✍ Scribed by Melissa A. Craft; Gail C. Davis; René M. Paulson

Book ID: 114731402
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 176 KB
Volume: 69
Category: Article
ISSN: 0309-2402
DOI: 10.1111/j.1365-2648.2012.06008.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot study of expressive writing inte

A pilot study of expressive writing intervention among Chinese-speaking breast cancer survivors.

✍ Lu, Qian; Zheng, Dianhan; Young, Lucy; Kagawa-Singer, Marjorie; Loh, Alice 📂 Article 📅 2012 🏛 American Psychological Association 🌐 English ⚖ 59 KB

Early-onset breast cancer in A-bomb surv

Early-onset breast cancer in A-bomb survivors

✍ CharlesE Land; Masayoshi Tokunaga; Shoji Tokuoka; Nori Nakamura 📂 Article 📅 1993 🏛 The Lancet 🌐 English ⚖ 151 KB

Effects of an expressive writing interve

Effects of an expressive writing intervention on cancer-related distress in Danish breast cancer survivors — results from a nationwide randomized clinical trial

✍ M. B. Jensen-Johansen; S. Christensen; H. Valdimarsdottir; S. Zakowski; A. B. Je 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Early detection of second breast cancers

Early detection of second breast cancers improves prognosis in breast cancer survivors

✍ Houssami, N.; Ciatto, S.; Martinelli, F.; Bonardi, R.; Duffy, S. W. 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 113 KB

Randomised trial of expressive writing f

Randomised trial of expressive writing for distressed metastatic breast cancer patients

✍ Mosher, Catherine E.; DuHamel, Katherine N.; Lam, Joanne; Dickler, Maura; Li, Yu 📂 Article 📅 2012 🏛 Taylor and Francis Group 🌐 English ⚖ 178 KB

Skeletal health in postmenopausal surviv

Skeletal health in postmenopausal survivors of early breast cancer

✍ John R. Mackey; Anil A. Joy 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 90 KB

## Abstract Estrogen plays an important role in the skeletal health of all women. Many therapies used in the treatment of breast cancer reduce estrogen levels and have the potential to affect bone negatively by increasing the risk of osteoporosis and associated bone fractures. The long‐term effects